Use of a Glass Ionomer Sealant in Molar Incisor Hypomineralization
1 other identifier
observational
15
1 country
1
Brief Summary
Molar Incisor Hypomineralization (MIH) is a worldwide widespread qualitative developmental defect of the dental enamel with a multifactorial aetiology defined in 2001 as an "hypomineralization of systemic origin affecting one or more permanent molars, usually first permanent molars (FPMs), with or without the involvement of one or more affected permanent incisors". Clinically MIH lesions appear as demarcated opacities with a creamy-white to yellow-brown colour depending on the severity of the defect that is classified as mild or severe (levels of severity) according to the European Academy of Pediatric Dentistry (EAPD) severity criteria. The distribution of the lesions is asymmetrical and their severity varies from a patient to another and also within the mouth of the same patient. Due to its porous structure with an altered prism organization and an increased content of proteins, the hypomineralized enamel has reduced mechanical properties and a lower refractive index if compared to the sound enamel. MIH is associated to a large number of objective and subjective problems as an altered aesthetics, an increased risk of plaque accumulation, caries, post-eruptive breakdown (PEB), reduced retention rates of adhesive materials, hypersensitivity and difficulty in anesthetizing the affected teeth making its management a challenging condition. Among preventive measures, pit-and-fissure sealants are a valuable and effective treatment to prevent occlusal caries in FPMs when they are still intact. However, since their efficacy is closely related to the sealant retention, they have to be monitored over time. When the molar to be sealed is fully erupted and isolation is adequate, resin-based sealants are indicated while if the moisture control is inadequate and/or the tooth is hypersensitive and patient is not sufficiently cooperative, low-viscous glass ionomer cements (GICs) are suggested as a temporary measure until the eruption is completed and both symptoms and cooperation are improved. To date, the scientific knowledge regarding the use of different type of sealants in MIH affected molars is insufficient to draw exhaustive conclusions and further studies are needed to deepen the knowledge on this topic. The aim of this study is to assess, by clinical examination, the survival rate of a glass ionomer sealant in MIH affected FPMs at 12 months of follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 28, 2023
CompletedFirst Posted
Study publicly available on registry
April 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2026
CompletedJune 14, 2024
June 1, 2024
3.6 years
March 28, 2023
June 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glass ionomer sealant survival rate
Percentage of satisfactory status sealant in FPMs affected by MIH
At 12-month follow up
Eligibility Criteria
Children aged between 6 and 10 years with erupted MIH affected FPMs presenting lesions on the occlusal surface
You may qualify if:
- FPMs of children aged between 6 and 10 years;
- Erupted MIH affected FPMs presenting lesions on the occlusal surface;
- Good general health conditions;
- Sufficient cooperative behaviour;
- Signature of the informed consent to the study by patients' parents or by their legal guardians
You may not qualify if:
- FPMs presenting fluorosis, amelogenesis imperfecta, white spots, or other enamel defects that are in differential diagnosis with MIH;
- FPMs presenting the occlusal surface already sealed or restored;
- FPMs presenting occlusal cavitated caries (ICDAS Pit and Fissures ≥ 3)
- FPMs presenting severe PEB involving the dentin;
- Children with orthodontic devices hiding FPMs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Burlo Garofolo
Trieste, 34137, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Milena Cadenaro, MD
IRCCS materno infantile Burlo Garofolo
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2023
First Posted
April 10, 2023
Study Start
June 1, 2022
Primary Completion
January 15, 2026
Study Completion
January 15, 2026
Last Updated
June 14, 2024
Record last verified: 2024-06